Modified FOLFOX plus/minus Nivolumab and Ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – A randomized phase 2 Trial
Chemo,Zielgerichtet - Therapieart: palliativ